B. Riley Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,692
Closed -$380K 1529
2021
Q4
$380K Buy
3,692
+302
+9% +$29K 0.01% 954
2021
Q3
$297K Buy
3,390
+504
+17% +$45.6K 0.01% 1044
2021
Q2
$259K Buy
+2,886
New +$244K 0.01% 1111
2021
Q1
Sell
-4,329
Closed -$295K 1427
2020
Q4
$295K Sell
4,329
-637
-13% -$39.7K 0.02% 763
2020
Q3
$267K Buy
4,966
+518
+12% +$30.8K 0.01% 743
2020
Q2
$260K Buy
+4,448
New +$239K 0.02% 677
2020
Q1
Sell
-4,402
Closed -$262K 917
2019
Q4
$262K Buy
+4,402
New +$237K 0.02% 653
2015
Q1
Sell
-250
Closed -$6 2117
2014
Q4
$6 Buy
+250
New +$5.95K ﹤0.01% 3111

Other funds holding SYNH

B. Riley Wealth Advisors's SYNH Position: Q1 2022 in Review

B. Riley Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 3,692 shares — an estimated $380K sold.

B. Riley Wealth Advisors first reported a position in SYNH in Q4 2014 and held it in 8 quarters. The position peaked at $380K in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • B. Riley Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 3,692 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $380K.
  • B. Riley Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 8 quarters.
  • B. Riley Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $380K in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2022, filed 2 May 2022.